Trang chủ
Cập nhật pháp chế24 thg 8, 2026•1 phút đọc

FDA Recalls Product Due to CGMP Deviations

Tác giả: đội ngũ PharmaCountry

The FDA has initiated a recall of a product because of deviations from current Good Manufacturing Practices (CGMP).

The U.S. Food and Drug Administration (FDA) has issued a recall for a pharmaceutical product after identifying deviations from current Good Manufacturing Practices (CGMP). The recall underscores the agency's focus on ensuring manufacturing compliance and product safety.

Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: FDA.gov